Early intermittent hyperlipidemia significantly accelerates atherosclerosis by disrupting macrophage function, highlighting the need for early cholesterol management.
Gilead renews IT contract with Cognizant in bid to more quickly bring drugs to market
Gilead is expanding and renewing an IT contract with Cognizant that is now worth up to $800 million over five years. Cognizant said Monday that